(Q41714456)

7 October 2017

title

Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. (English)

1 reference

7 October 2017

1 reference

1 reference

7 October 2017

Cory S

1 reference

7 October 2017

Harris AW

1 reference

7 October 2017

Bath ML

series ordinal

1 reference

7 October 2017

language of work or name

English

0 references

publication date

1 November 1990

1 reference

7 October 2017

1 reference

7 October 2017

volume

348

1 reference

7 October 2017

issue

6299

1 reference

7 October 2017

page(s)

331-333

1 reference

Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation

7 October 2017

cites work

1 reference

7 January 2021

Cloning the chromosomal breakpoint of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18.

1 reference

7 January 2021

Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocation

1 reference

7 January 2021

The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation

1 reference

7 January 2021

Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proliferation

1 reference

7 January 2021

Expression of Bcl-2 and Bcl-2-Ig fusion transcripts in normal and neoplastic cells

1 reference

7 January 2021

Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells

1 reference

7 January 2021

BCL2-mediated tumorigenicity of a human T-lymphoid cell line: synergy with MYC and inhibition by BCL2 antisense

1 reference

7 January 2021

Growth- and tumor-promoting effects of deregulated BCL2 in human B-lymphoblastoid cells

1 reference

7 January 2021

bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation

1 reference

7 January 2021

Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population

1 reference

7 January 2021

The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice

1 reference

7 January 2021

The c-myc oncogene perturbs B lymphocyte development in Eμ-myc transgenic mice

1 reference

7 January 2021

The E mu-myc transgenic mouse. A model for high-incidence spontaneous lymphoma and leukemia of early B cells

1 reference

7 January 2021

Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model

1 reference

7 January 2021

PB76: a novel surface glycoprotein preferentially expressed on mouse pre-B cells and plasma cells detected by the monoclonal antibody G-5-2.

1 reference

7 January 2021

Purification and characterization of mouse hematopoietic stem cells

1 reference

7 January 2021

L3T4 antigen expression by hemopoietic precursor cells

1 reference

7 January 2021

Expression of the 6C3 antigen on murine hematopoietic neoplasms. Association with expression of abl, ras, fes, src, erbB, and Cas NS-1 oncogenes but not with myc.

1 reference

7 January 2021

Il-3-dependent mouse clones that express B-220 surface antigen, contain Ig genes in germ-line configuration, and generate B lymphocytes in vivo.

1 reference

7 January 2021

Continuing rearrangement of immunoglobulin and T-cell receptor genes in a Ha-ras-transformed lymphoid progenitor cell line

1 reference

7 January 2021

Lambda 5, a new light-chain-related locus selectively expressed in pre-B lymphocytes

1 reference

7 January 2021

The V(D)J recombination activating gene, RAG-1.

1 reference

7 January 2021

Identification of a novel bone marrow-derived B-cell progenitor population that coexpresses B220 and Thy-1 and is highly enriched for Abelson leukemia virus targets

1 reference

7 January 2021

A 14;18 and an 8;14 chromosome translocation in a cell line derived from an acute B-cell leukemia

1 reference

7 January 2021

Evolution of B-cell malignancy: pre-B-cell leukemia resulting from MYC activation in a B-cell neoplasm with a rearranged BCL2 gene

1 reference

7 January 2021

Activation of MYC in a masked t(8;17) translocation results in an aggressive B-cell leukemia

1 reference

7 January 2021

An attempt to produce "pre-T" cell hybridomas and to identify their antigens

1 reference

7 January 2021

A bcr-v-abl oncogene induces lymphomas in transgenic mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/348331A0

1 reference

Dimensions Publication ID

7 October 2017

1019679922

0 references

1 reference